HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$1.86
Day range
$1.85 - $1.95
Year range
$0.86 - $2.46
Market cap
118.12M USD
Avg Volume
204.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.54M | -9.43% |
Net income | -26.45M | 11.13% |
Net profit margin | — | — |
Earnings per share | -0.44 | 12.00% |
EBITDA | -26.50M | 17.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.61M | -36.80% |
Total assets | 142.22M | -46.73% |
Total liabilities | 49.05M | -1.46% |
Total equity | 93.17M | — |
Shares outstanding | 60.57M | — |
Price to book | 1.20 | — |
Return on assets | -42.20% | — |
Return on capital | -48.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -26.45M | 11.13% |
Cash from operations | -30.49M | -23.96% |
Cash from investing | 40.51M | 499.83% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 10.02M | 128.82% |
Free cash flow | -21.75M | -47.66% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
61
